Stocks · Health care · Biological Products, (No Diagnostic Substances)

Century Therapeutics, Inc.

IPSC Clue Score63
United States Fiscal year ends December CIK 0001850119 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Chad Cowan
22 Dec 2025
Chief Scientific Officer
Buy
58,060
$0.85
$49.25K
Brent Pfeiffenberger
12 Dec 2025
President and CEO
Buy
52,000
$0.58
$30.35K
Brent Pfeiffenberger
19 Nov 2025
President and CEO
Buy
35,000
$0.50
$17.33K
Daphne Quimi
12 Sep 2024
Director
Buy
5,000
$1.53
$7.66K
Eli Casdin
22 Jun 2021
Director
Buy indirect
750,000
$20.00
$15.00M
Versant Venture Capital VI, L.P.
22 Jun 2021
10% owner
Buy indirect
100,000
$20.00
$2.00M
Aktiengesellschaft Bayer
22 Jun 2021
10% owner
Buy
750,000
$20.00
$15.00M

What was left out

Form 4 filings counted 163
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 6
Sales at will 50
Transactions with no price 0
Shares from compensation/vesting 36,941,556
Sales filed before the plan box existed 1
History held since 21 Jun 2021